ArticleBMC bioinformatics2025
RMDNet: RNA-aware dung beetle optimization-based multi-branch integration network for RNA-protein binding sites prediction.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Sequence-Based Models for RNA-Protein Interactions Imputation Might Be Insufficient for Novel Signal Prediction in eCLIP Data.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
RNA-binding proteins (RBPs) play crucial roles in gene regulation. Their dysregulation has been increasingly linked to neurodegenerative diseases, liver cancer, and lung cancer. Although experimental methods like CLIP-seq accurately identify RNA-protein binding sites, they are time-consuming and costly. To address this, we propose RMDNet-a deep learning framework that integrates CNN, CNN-Transformer, and ResNet branches to capture features at multiple sequence scales. These features are fused with structural representations derived from RNA secondary structure graphs. The graphs are processed using a graph neural network with DiffPool. To optimize feature integration, we incorporate an improved dung beetle optimization algorithm, which adaptively assigns fusion weights during inference. Evaluations on the RBP-24 benchmark show that RMDNet outperforms state-of-the-art models including GraphProt, DeepRKE, and DeepDW across multiple metrics. On the RBP-31 dataset, it demonstrates strong generalization ability, while ablation studies on RBPsuite2.0 validate the contributions of individual modules. We assess biological interpretability by extracting candidate binding motifs from the first-layer CNN kernels. Several motifs closely match experimentally validated RBP motifs, confirming the model's capacity to learn biologically meaningful patterns. A downstream case study on YTHDF1 focuses on analyzing interpretable spatial binding patterns, using a large-scale prediction dataset and CLIP-seq peak alignment. The results confirm that the model captures localized binding signals and spatial consistency with experimental annotations. Overall, RMDNet is a robust and interpretable tool for predicting RNA-protein binding sites. It has broad potential in disease mechanism research and therapeutic target discovery. The source code is available https://github.com/cskyan/RMDNet .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.